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Abstract
Background: Transgenic mice with mosaic, Golgi-staining-like expression of enhanced green fluorescent protein (EGFP)
have been very useful in studying the dynamics of neuronal structure and function. In order to further investigate the
molecular events regulating structural plasticity, it would be useful to express multiple proteins in the same sparse neurons,
allowing co-expression of functional proteins or co-labeling of subcellular compartments with other fluorescent proteins.
However, it has been difficult to obtain reproducible expression in the same subset of neurons for direct comparison of
neurons expressing different functional proteins.
Principal Findings: Here we describe a Cre-transgenic line that allows reproducible expression of transgenic proteins of
choice in a small number of neurons of the adult cortex, hippocampus, striatum, olfactory bulb, subiculum, hypothalamus,
superior colliculus and amygdala. We show that using these Cre-transgenic mice, multiple Cre-dependent transgenes can
be expressed together in the same isolated neurons. We also describe a Cre-dependent transgenic line expressing a
membrane associated EGFP (EGFP-F). Crossed with the Cre-transgenic line, EGFP-F expression starts in the adolescent
forebrain, is present in dendrites, dendritic protrusions, axons and boutons and is strong enough for acute or chronic in vivo
imaging.
Significance: This triple transgenic approach will aid the morphological and functional characterization of neurons in
various Cre-dependent transgenic mice.
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Introduction
The development and functionality of the central nervous
system involves complex interactions between various neuronal
cell types. Therefore, tools that allow us to visualize isolated
neurons of a particular class are of immense help in the analysis of
the dynamic connectivity during development and adulthood. For
more than a century, the majority of morphological studies in
neuroscience at the cellular and subcellular level have been carried
out using the Golgi approach to stain individual neurons [1] and
visualize their dendrites and dendritic protrusions. Although this
approach has been vital for the elucidation of the structural details
of the central nervous system, it is not suitable for examining the
dynamic functions of neurons.
The advent of green fluorescent protein (GFP) as a tool to label
cells [2] together with live cell imaging by confocal- [3–6] or two
photon microscopy [7–10] have permitted the study of dynamic
structural changes occurring with development and plasticity of
the central nervous system in vivo [11–13]. Various methods have
been developed to express GFP in sparse neurons in vitro and in
vivo, necessary for studying neuronal morphology. Particle-
mediated gene transfer allows labeling of individual neurons in
slice cultures [14]. Viral-mediated gene delivery has proven ideal
for mosaic gene expression in vivo [15,16] but can also be used in
slice cultures [17,18].
Transgenic approaches, though more time consuming, have the
advantage of being non-invasive and less variable. Transgenic
mice expressing various spectral variants of GFP under the control
of the Thy1 promoter, with distinct expression patterns in the
cortex have been produced [19] and proved very useful for the
analysis of the dynamics of synapse formation and pruning in vivo
[20–22]. Unfortunately, only limited expression patterns are
currently available, making it impossible to study synapse
dynamics of other structures in the CNS including the supra-
granular layers of the visual cortex.
For studying molecular mechanisms regulating dynamics of
morphological changes, similar transgenic mice with two addi-
tional features are necessary. The first is that the mosaic expression
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pattern can be reproduced with novel fluorescent- or functional
transgenic proteins to allow direct comparison of their effects in
the exact same subset of neurons. The second feature is that
multiple transgenes can be expressed in the same individual
neurons. This allows the labeling of neuronal morphology with
GFP and the concurrent expression of fluorescent synaptic
markers or functional transgenes enabling the analysis of cell
autonomous processes and the dissociation of pre- and postsyn-
aptic mechanisms.
The first feature has been achieved previously by making use of
the Cre/Lox system to achieve mosaic transgene expression. The
mosaic expression pattern is defined by the Cre-transgenic mice and
crossing them to lines carrying different Cre-dependent transgenes
allows their expression in a reproducible fashion. Only four such
mice have been described until now. The first line shows expression
in very low numbers of excitatory neurons in the neocortex in a
columnar pattern [23]. As the localization of these columns is
unpredictable, these mice are not very suitable for in vivo two
photon imaging. The other lines express hormone-analogue
inducible versions of the Cre recombinase. [24–26]. Though useful
for addressing questions depending on precise timing of transgene
expression, the main caveat of this approach is that concentrations
of estrogen homologues required for activating Cre approach those
that affect dendritic growth and spine morphology [27].
The second feature, expressing multiple transgenes in the same
individual neurons, has been very difficult to achieve. Although it
is theoretically possible to express two proteins in a Cre-dependent
fashion using bicistronic vectors, this approach usually results in
relatively low expression of one of the transgenic proteins in vivo.
Recently, a novel technology named ‘‘mosaic analysis with double
markers’’ (MADM) was introduced, which allows the mosaic
expression of multiple fluorescent proteins and manipulation of
endogenous genes at the same time [28]. Though a powerful
approach, it is technically very demanding, involving the
production of multiple gene-targeted animals for each gene of
interest to be studied or fluorescent protein to be expressed.
To overcome these issues, we describe here a Cre-transgenic
line that can mediate expression of multiple Cre-dependent
transgenes of choice in very few neurons of the adolescent
neocortex, hippocampus, olfactory bulb, striatum, amygdala,
hypothalamus and superior colliculus. Moreover, a novel Cre-
dependent GFP transgenic line is described allowing chronic
imaging of synaptic structures when combined with the mosaic
Cre-line.
Results
Generation of transgenic mice
Transgenic mice were generated based on the Cre/Lox-
recombination approach [29]. Using a construct encoding the
Cre recombinase under the control of the Calcium/Calmodulin
dependent kinase IIa (CaMKIIa) promoter (Fig. 1A) four founders
were created. These lines defined the expression pattern and onset
of reporter gene expression. Initially they were crossed with R26R
mice that express the b-galactosidase gene under the endogenous
ROSA26 promoter in a Cre-dependent fashion [30]. This allowed
us to check for the efficiency of Cre recombination by analyzing
the expression pattern of b-galactosidase expression. The offspring
of two founder lines (Cre 3487 and 3510) showed Cre
recombination in a small subset of cells (Fig. 1B and 1C). Line
Cre 3510 showed columnar Cre recombination similarly to the
mice described earlier. Line Cre 3487 showed a more even
distribution of labeled neurons over the neocortex and hippocam-
pus and was used in all subsequent experiments.
The second construct used for the production of transgenic
animals mediated expression of EGFP-F under the control of the
Thy1 promoter (Fig. 1A). A transcriptional STOP cassette flanked
by two loxP sites was inserted between the promoter and coding
region, ensuring that the timing and expression pattern of this
transgene was dependent on the Cre-transgenic animals they were
to be crossed to. Ten EGFP-F founder lines were created and
crossed initially to a broad expressing Cre-transgenic line. One of
the lines, TLG 498, showed good levels of EGFP-F expression, in
more than 90% of pyramidal neurons in the neocortex and
hippocampus. Another line, TLG 696, showed good expression
levels of EGFP-F, but only in 60–70% of all pyramidal neurons.
Line TLG 1157 expressed high levels of EGFP-F in all pyramidal
neurons. Line TLG 706 showed extremely high levels of EGFP-F
causing the protein to accumulate in the soma. Most quantitative
data was obtained with line TLG 498 as it was the first line
produced with good EGFP-F expression levels. Line TLG 1157
showing higher expression levels of EGFP-F was produced later
and was used predominantly for in vitro and vivo imaging
experiments.
Cre-mediated transgenes are expressed in individual
neurons of the adult brain
In TLG 498+ Cre 3487+ double transgenic animals, mosaic
EGFP-F expression started at around 5–6 weeks after birth and
accumulated during the following weeks (Fig. 1 D–E). Immuno-
histochemical staining for the neuronal marker NeuN confirmed
that transgene expression was confined to neurons (Fig. 2B).
EGFP-F+ cells in the neocortex and hippocampus did not express
GABA, a marker for inhibitory neurons (Fig. 2C). Both in TLG
498+ Cre 3487+ and TLG 1157+ Cre 3487+ double transgenic
animals EGFP-F fluorescence was detected in pyramidal neurons
predominantly in layer II/III, but also V and VI of the neocortex
(Fig. 3A–B) and in pyramidal and granule cells of the
hippocampus (Fig. 3C–D). Within the neocortex, EGFP-F
expressing neurons were observed in the visual cortex, somato-
sensory cortex, auditory cortex, lateral orbital cortex, piriform
cortex, agranular insular cortex and retrospenial agranular cortex.
EGFP-F expression in individual cells was also observed in the
olfactory bulb (Fig. 3E–F), subiculum, hypothalamus, striatum,
amygdala (Fig. 3G–H) and superior colliculus (Fig. 3I–J). There
was no expression in the thalamic nuclei or cerebellum (Fig. 3K–
L). Counterstaining the sections with Hoechst 33342 allowed the
determination of recombination efficiency. In the visual cortex,
approximately one out of a thousand cells expressed EGFP-F
(Fig. 2A) whereas more cells recombined in the agranular insular,
cortex and hippocampus. In order to represent this low
recombination efficiency in a more practically applicable manner,
we counted the total number of EGFP-F+ cells from various
regions of interest from 50 mm thick sections of TLG 498+ Cre
3487+ tanimals (Table 1). Morphological analyses in TLG 498+
Cre 3487+ and TLG 1157+ Cre 3487+ double positive animals
identified EGFP-F+ neurons in the extragranular layers (II, III, V
and VI) of the neocortex (Fig. 4A–B), amygdala (Fig. 4C–D), and
in hippocampal CA1 (Fig. 4E–F) and CA3 as pyramidal cells, and
as granule cells in dentate gyrus (Fig. 4G–H). In superior colliculus
only marginal cells and piriform neurons expressed EGFP-F
(Fig. 4I–J). Striatal EGFP-F+ expressing cells were medium spiny
projection neurons (Fig. 4K–L), while in olfactory bulb, EGFP-F+
cells were granule cells (Fig. 4M–N). In the hypothalamus, EGFP-
F was expressed by the tubero-mammillary neurons (Fig. 4O–P).
These EGFP-F+ neurons conform to the subset of cell types which
express high levels of endogenous CaMKIIa. Frequently, several
Mosaic Transgene Expression
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EGFP-F expressing neurons were found in close proximity to each
other.
Multiple transgenes can be expressed in the same
neuronal population
For studying molecular mechanisms underlying structural
plasticity, it is often required to express multiple transgenes in
the same individual neurons. Therefore, we tested whether in
TLG 498+ R26R+ Cre 3487+ triple transgenic mice, both EGFP-F
and b-galactosidase would be expressed in the same individual
neurons.
TLG 498+ R26R+ Cre 3487+ triple transgenic mice were
generated by first producing mice double transgenic for the marker
genes (TLG 498+ and R26R+). Next, these mice were crossed with
Cre 3487 transgenic animals. The offspring that were TLG 498+
R26R+ Cre 3487+ were used to determine the percentage of EGFP-
F+ cells that expressed b-galactosidase. We generally avoided using
Figure 1. Generation of Cre-dependent mosaic transgenic mice. (A) Transgenic mice based on Cre/Lox recombination were generated by
crossing a Cre-transgenic line under a CaMKIIa promoter with a Thy1 promoter-driven EGFP-F transgenic line containing a transcriptional STOP
cassette. Bright field microscopy images showing mosaic expression of the b-galactosidase expressing cells in layers II/III and V/VI of the neocortex of
R26R mice when crossed with different CaMKIIa promoter-driven Cre-transgenic lines – (B) Cre 3487 and (C) Cre 3510. Epi-fluorescence microscopy
images of Cre-dependent EGFP-F expression in TLG 498+ Cre 3487+ transgenic mice. EGFP-F expression starts at 6 weeks and increases with age. The
number of EGFP-F+ cells increases from (D) 2 months to (E) 4 months of age. Scale bars: B, D-100 mm; C-200 mm.
doi:10.1371/journal.pone.0003059.g001
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TLG 498+ Cre 3487+ transgenic mice for further breeding, as
germline recombination sometimes occurred resulting in broad
EGFP-F expression in the next generation. In case the breeding of
mice carrying a floxed gene and Cre 3487+ is essential for some
reason, we recommend genetic testing of the offspring to exclude
germline recombination before use or further breeding.
Figure 2. Mosaic expression of EGFP-F in the cortex is confined to excitatory neurons. (A) A confocal image of a 50 mm section of the
visual cortex of two month old TLG 498+ Cre 3487+ transgenic mice for antibodies against GFP (green) and counterstained with Hoechst 33342 (blue
nuclei) shows the low recombination efficiency. (B) Double immunofluorescence for antibodies against GFP (green) and the neuronal marker NeuN
(red) show colocalization of NeuN in EGFP-F expressing cells. (C) In the cortex there is no colocalization of EGFP-F with GABA, a marker for inhibitory
neurons (red). Scale bar: 50 mm.
doi:10.1371/journal.pone.0003059.g002
Figure 3. Mosaic transgene expression in various parts of the adult forebrain. Epi-fluorescence microscopy images showing expression of
EGFP-F in TLG 498+ Cre 3487+ transgenic mice at 2 months of age in (A) pyramidal cells in layers II/III and V/VI of visual cortex, C) pyramidal and
granule cells of hippocampus, (E) granule cells of the olfactory bulb, (G) pyramidal cells of amygdala and (I) piriform cells in superior colliculus
(arrows). There is no expression in the cerebellum (K). Scale bar 2200 mm. A very similar expression pattern was observed in 2K month old TLG
1157+ Cre 3487+ transgenic mice as shown in the juxtaposed figures (same scale): (B) pyramidal cells in visual cortex, (D) granule cells of
hippocampus, (F) granule cells of the olfactory bulb, (H) pyramidal cells of amygdala, and (J) piriform cells in superior colliculus. Again, no expression
was observed in cerebellum (L).
doi:10.1371/journal.pone.0003059.g003
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TLG 498+ R26R+ Cre 3487+ offspring were used for cell
counts. b-galactosidase was predominantly present close to the
soma and partly in the proximal dendrites whereas EGFP-F was
seen throughout the neuron (Fig. 5). Cell counts showed that 80–
90% of EGFP-F+ cortical cells in layer II/III and V/VI also
expressed b-galactosidase (Table 2) and a similar percentage of b-
galactosidase+ neurons also expressed EGFP-F.
Visualization of neuronal structures of EGFP-F expressing
neurons
We next analyzed whether the subcellular localization of
EGFP-F allowed the analysis of neuronal structures. The
farnesylation modification of EGFP ensured it to be targeted to
the membrane (Fig. 6A and B, line TLG 1157 shown). EGFP-F
fluorescence was detected evenly distributed throughout the
membrane of the cell including the dendritic spines (Fig. 6A–B)
and axons (Fig. 6C). Small and thin spines, the stalks of large
spines as well as filopodia could be clearly visualized. Both types
of axonal boutons – en passant and terminaux – were labeled
with EGFP-F (Fig. 6C). Subcellular distribution of EGFP in line
TLG 498 was the same, albeit a lower expression levels [31].
Biocytin injections confirmed that all dendritic protrusions were
labeled with EGFP-F [31]. We did notice that in both lines, cells
expressed varying levels of EGFP-F, which may possibly depend
on the number of copies of the transgene that are activated by
Cre recombination.
Strong expression of EGFP-F allows chronic in vivo
imaging of neurons and dendritic protrusions
The advantage of using GFP variants to label neurons is the
ability to follow dynamic changes in cellular and subcellular
compartments. Here, we tested if the levels of EGFP-F expression
in TLG 498+ Cre 3487+ and TLG 1157+ Cre 3487+ double
transgenic mice were sufficient for in vivo two photon imaging. In
TLG 498+ Cre 3487+ double transgenic animals, only the
brightest EGFP-F expressing cells in layers II/III, V or VI could
be imaged with in vivo two-photon microscopy and dendritic
protrusions, axons and their boutons were visible in such cells
(Fig. 6D). EGFP-F expressing neurons were, however, often not
bright enough for repeated imaging in TLG 498+ Cre 3487+ mice
(data not shown). In contrast, EGFP-F expressing cells could be
imaged without difficulty in TLG 1157+ Cre 3487+ mice and
EGFP-F levels were more than sufficient for repeated imaging
(Fig 6E and F).
Discussion
In vivo two–photon imaging of transgenic mice with mosaic,
Golgi-staining like GFP expression has made the analysis of the
dynamics of structural changes in neurons possible. This approach
has resulted in the elucidation of its basic properties including the
stability and turnover of dendritic spines of neurons from various
cortical regions during early developmental and in adult mice [20–
22]. Importantly, it has provided insight into the effects of sensory
experience and neuronal activity on the motility and stability of
dendritic spines and filopodia [13,32–34]. However, many
fundamental questions still remain unanswered. For example, it
is still unknown how changes in the precise connectivity between
different subsets of neurons mediate the functional changes that
are achieved, which molecular and cellular processes regulate
these events and why increased plasticity can take place during
sensitive periods. Here we describe Cre- and membrane associated
EGFP (EGFP-F)-transgenic lines allowing the co-expression of
multiple independent transgenes in the same isolated neurons in
various brain areas starting 5–6 weeks after birth. This late onset of
Cre-recombination allows studying the involvement of specific
proteins in the adult CNS as unwanted effects of transgene
expression during development are avoided. The mice will be a
welcome new tool for studying molecular events regulating
synapse dynamics in the adult brain as proteins of choice can be
expressed in a reproducible manner, allowing direct comparison of
neurons expressing multiple fluorescent and/or functional pro-
teins.
In line Cre-3487, expression of Cre is driven by the CamKIIa
promoter and results in mosaic activation of Cre-dependent
reporter genes in brain areas and cell types known to express high
levels of endogenous CamKIIa. These cell types include
pyramidal neurons of layers II/III and V/VI of the neocortex,
pyramidal cells of CA1 and CA3, and granule cells of the dentate
gyrus. Recombination also occured in pyramidal neurons in
amygdala; marginal and piriform cells in the superior colliculus;
medium spiny projection neurons in striatum, granule cells in the
olfactory bulb and tubero-mammillary neurons in the hypothal-
amus.
We initially believed that the mosaicism mediated by the
CamKII-Cre transgene was caused by low – rather than mosaic –
expression of the Cre recombinase, translating into infrequent
(stochastic) activation of Cre-dependent transgenes. We reasoned
that in that case the likelihood that multiple Cre-dependent
transgenes would be activated in the same individual neurons is
very small. However, after crossing in two Cre-dependent
transgenes (encoding EGFP-F and b-galactosidase respectively)
we observed that 80–90% of cortical neurons expressing one
transgene also expressed the other, suggesting that Cre-expression
itself is mosaic. Moreover, considering the high level of co-
expression of these independent Cre-dependent transgenes and
our observation that two different Cre-dependent EGFP-F
Table 1. Recombination efficiencies in various areas of the
adult brain.
Region Cell Type
Number of
EGFP+ cells
Motor Cortex Pyramidal 1664.7
Somatosensory Cortex Pyramidal 7.662.0
Visual Cortex Pyramidal 7.264.5
Retrosplenial Granular Cortex Pyramidal 2.361.9
Subiculum NV 1.861.0
Hippocampus – CA Pyramidal 1167.5
Hippocampus - Dentate Gyrus Granule 1364.5
Striatum Medium spiny projection 3.462.2
Olfactory Bulb Granule 2967.8
Anterior Olfactory Nucleus NV 6.362.7
Olfactory Tubercle NV 1062.8
Amygdala Pyramidal 2.261.6
Hypothalamus Tubero-mammillary 5.363.2
Superior Colliculus Piriform and Marginal 2.161.6
EGFP-F+ cells were counted from various brain regions of four 2 month old TLG
498+ Cre 3487+ mice. A total of 17 sections of 50 mm thickness were used. The
average number of EGFP-F expressing cells/section in each part of the forebrain
is shown. Error bars represent standard deviation between sections. Cell types
were identified by morphology alone. NV – not verified.
doi:10.1371/journal.pone.0003059.t001
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transgenic lines showed transgene expression in the same sparse
neuronal subsets when crossed to the Cre-3487 line, we conclude
that the mosaic expression pattern observed is caused by the Cre-
3487 line and not by the reporter lines.
Mosaic expression of fluorescent proteins in the CNS is essential
for studying dynamic changes of synaptic connectivity using live
imaging techniques. In our new Cre-dependent EGFP-F line,
TLG 1157, EGFP-F expression in pyramidal neurons of layers II/
III, V and VI was sufficient to permit acute and chronic in vivo
imaging of neurites and synaptic structures when crossed to Cre-
3487 transgenic mice. These double transgenic mice will be an
attractive new addition to the extensively used mosaic GFP
transgenic lines produced by Feng et al. [19], especially because
none of these lines show extensive GFP expression in layer II/III
neurons in the primary visual cortex. We anticipate that the Cre-
and EGFP-F transgenic animals described here will also be useful
for studying molecular mechanisms regulating neuronal function
and plasticity. As multiple transgenes can be expressed in the same
isolated neurons using the Cre-3487 transgenic animals, it should
be possible to express other transgenes together with EGFP-F from
line TLG 1157. Such transgenes may encode fusion proteins with
red fluorescent proteins labeling subcellular structures of choice
allowing the analysis of synapse formation, vesicle transport,
cytoskeletal rearrangements or other processes with live cell
Figure 4. Cre-dependent EGFP-F labels distinct neuronal types in the adult forebrain. Confocal microscopy images showing that mosaic
EGFP-F expression in a 2 month old TLG 498+ Cre 3487+ mouse occurs in pyramidal cells in (A) neocortex, (C) amygdala and (E) hippocampal CA1; (G)
granule cells in the dentate gyrus; (I) marginal cells in the superior colliculus; (K) spiny projection neurons in the striatum; (M) granule cells in the
olfactory bulb and (O) tubero-mammillary cells in the posterior hypothalamus. Scale bar 250 mm.Mosaic EGFP-F expression in a 2K month old TLG
1157+ Cre 3487+ transgenic mouse occurs in the same cell types as shown by the juxtaposed figures (B, D, F, H, J, L, N, P – same scale as juxtaposed
images).
doi:10.1371/journal.pone.0003059.g004
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imaging techniques if sufficiently high expression levels are
accomplished. Alternatively, proteins altering specific signaling
pathways can be expressed. In this case it would be advisable to
co-express a red fluorescent protein using an internal ribosomal
entry site in order to allow monitoring for co-expression of both
transgenes as this will not occur in all neurons. Considering that by
making use of the Thy1-promoter in combination with a floxed
stop cassette, one out of ten EGFP-F transgenic founders had high
enough expression for chronic imaging of small structures and two
more had sufficient expression for identification of transgene
expressing neurons, this approach seems highly feasible. Of course,
Cre-dependent reporter lines other than the EGFP-F lines
described here can be utilized in combination with line Cre-
3487. Especially using the recently described Brainbow reporter
mice [36] provides interesting options as it will allow studying the
effects of specific signaling pathways on synaptic connectivity in
exquisite detail.
Materials and Methods
DNA constructs and production of transgenic mice
The construct for expressing the EGFP-F in neurons in a Cre-
dependent fashion was created as described previously [31]. In
short: the lox-Stop-lox (LSL) cassette from PBS302 (Gibco-BRL,
Bethesda, MD) was cloned into a Thy1 promoter containing
expression vector, rendering pThy-LSL. pThyLSL-EGFP-F was
created by cloning the fragment encoding EGFP fused to the H-
Ras farnesylation site from pEGFP-F (BD Biosciences, Mountain
View, CA) into pThy-LSL. For production of transgenic mice
expressing Cre under the control of the CaMKIIa promoter,
pJTCre [37] was employed (Fig. 1A). Transgenic mice were
created by pronuclear injections of linearized DNA into fertilized
C57BL/6 oocytes. All mice analyzed were in kept in or
backcrossed to C57BL/6 background for at least 5 generations.
To initially analyze the recombination efficiency in new Cre-
transgenic founders, we crossed them to R26R reporter mice. All
experiments involving mice were approved by the institutional
animal care and use committee of the Royal Netherlands
Academy of Arts and Sciences. Cre- and transgenic lines can be
obtained from the transgenic unit of the Netherlands Institute for
Neuroscience by contacting the corresponding author.
Histology and immunohistochemistry
Mice of various ages (4–20 weeks) were anaesthetized with
0.1 ml/gr bodyweight Nembutal (Janssen Pharmaceutical, UK)
and transcardially perfused with 4% paraformaldehyde (PFA) in
PBS. Triple transgenic mice were perfused at 8 weeks. Brains were
post-fixed for 2 hrs and stored at 4uC in PBS. Coronal sections of
50 mm were made using a vibratome (Leica VT1000S, Leica,
Rijswijk, Netherlands). Immunohistochemistry was performed on
free-floating sections using mouse anti-GFP antibodies (1:500,
Chemicon) followed by Alexa 568 conjugated goat anti-mouse IgG
antibodies (1:500, Molecular Probes). Subsequent to the incuba-
tion with secondary antibodies, sections were counterstained with
5 mg/ml Hoechst 33342 (Sigma) for 5 minutes and then washed
three times with PBS containing 0.1% Triton.
Table 2. Colocalization of EGFP-F and b-galactosidase in TLG 498+ R26R+ Cre 3487+ mice.
Cortical Layer % Colocalization of b-galactosidase and EGFP-F
+
EGFP-F+ cells expressing b-galactosidase b-galactosidase+ expressing EGFP-F
Layer II/III 79.5% (120/151) 92.3% (120/130)
Layer V/VI 87% (33/38) 92% (33/35)
Two month old TLG 498+ R26R+ Cre 3487+ transgenic mice were analyzed for colocalization of b-galactosidase in EGFP-F+ cells of the visual cortex. A total of 8 sections
of 100 mm thickness were used from 3 mice and 201 cells were counted. Numbers between brackets are absolute numbers of cells counted. Between 80–90% of
neurons expressing b-galactosidase also express EGFP-F and vice versa.
doi:10.1371/journal.pone.0003059.t002
Figure 5. Multiple transgenes can be expressed in the same cell. As determined by confocal microscopy, the resulting R26R+ TLG 498+ Cre
3487+ offspring express both EGFP-F (green) and b-galactosidase (red) in a Cre-dependent fashion. b-Galactosidase is predominantly localized
perinuclearly and partly in the dendrites whereas EGFP-F labels the entire neuron. Scale bar: B 225 mm.
doi:10.1371/journal.pone.0003059.g005
Mosaic Transgene Expression
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Double immunohistochemistry for EGFP-F and additional
histochemical markers was performed using chicken anti-GFP
antibodies (1:1000, Chemicon) followed by Alexa488 conjugated
anti-chicken IgG antibodies (1:500, Molecular Probes) and rabbit
anti-GABA (1:100, Medical Performance Products, The Nether-
lands) followed by Alexa 568 conjugated anti-rabbit IgG
antibodies (1:500, Molecular Probes) or mouse anti-NeuN
(1:100, Chemicon) followed by Alexa 568 conjugated anti-mouse
IgG antibodies (1:500, Molecular Probes). Double immunohisto-
chemistry for EGFP-F and b2galactosidase were performed with
biotin-labeled mouse anti-b2galactosidase antibodies (1:1000;
Sigma) followed by Cy3 conjugated streptavidin (1:500, Vector
Laboratories) along with chicken anti-GFP antibodies followed by
Alexa 488 conjugated secondary antibody. For enzymatic b-
galactosidase detection, brain sections from the R26R mice
crossed with Cre transgenic animals were incubated for 1 hour
at 37uC with X-Gal-solution containing 5 mM K4Fe(CN)6, 5 mM
K3Fe(CN)6, 2 mM MgCl2, 1 mg/ml 5-bromo4-chloro-3-indolyl-
D-galactoside (Invitrogen, Carlsbad, CA) in PBS. The X-Gal
reacted sections were washed with PBS, dehydrated and
embedded in entellan mounting medium.
Microscopy, image analysis and cell counts
Stained or unstained EGFP-F expressing neurons were imaged
using a Leica DRM microscope (Leica-Microsystems, Bensheim,
Germany) for epifluorescence images, or using a Carl Zeiss CLSM
510 Meta confocal microscope (Zeiss, Goettingen, Germany) with
Argon (488 nm) and HeNe (543 nm) lasers. Hoechst 33342
stained sections were imaged with a tunable Ti:Sapphire laser
(Mai Tai, Spectraphysics, Darmstadt, Germany) running at
725 nm. Confocal images were made using a 206 objective (0.5
NA) with 1 mm steps in the z-plane. Spines and axons were imaged
at a pixel resolution of 60 nm (636 oil objective, 1.4 NA, and an
optical zoom of 2.56) with 200 nm steps in the z-plane. The back-
projected pinhole was 190 nm. For each image acquisition of
whole neurons, the laser intensity and detector gain were adjusted
so that the entire detector range was used for the dendrites. When
imaging at a higher magnification, the detector range was set for
the spines and axons.
Recombination efficiency was determined by counting the
number of EGFP-F+ cells on sections that were stained with anti-
GFP antibodies. Different brain regions where identified by
making use of the Paxinos mouse brain atlas and the number of
EGFP-F expressing neurons in that region where counted.A total
of 17 sections of 50 mm thickness were used from four 2 month old
mice.
In vivo two-photon imaging
Two to four month old mice were imaged using in vivo two-
photon microscopy. The mice were anesthetized and maintained
with intraperitoneal injections of Fentanyl: (0.05 mg/kg), Mid-
azolam: (5.0 mg/kg), Medetomidin: (0.5 mg/kg). The depth of
anaesthesia was tested by foot-pinch reflex. A homeostatic heating
blanket was used to maintain the body temperature at 37uC and
the heart rate was monitored by placing the front and hind paws of
the mouse on electrodes with hydrogel. Atropine and dexameth-
asone were given subcutaneously to the mice before surgery. The
skull was removed overlying the visual cortex using a motorized
drill. The dural surface was covered by a thin layer of 1.2%
agarose and a coverslip (5 mm diameter), whose edges were
subsequently sealed by dental acrylic. A thin titanium head bar
was attached next to the cranial window. Neurons were imaged
with a custom-built microscope and a mode-locked Ti:sapphire
laser (Mai Tai, Spectra-Physics) at 910 nm through a 406water
immersion objective (0.8 NA, Olympus). Scanning and image
acquisition were controlled by Fluoview software (Olympus). The
average power delivered to the brain was ,50 mW. Images stacks
(102461024 pixels, in 0.5 um steps) of different magnifications
were taken within the upper 100 mm from the pial surface. In
acute experiments, mice were imaged immediately following
surgery. In chronic experiments, the animals were imaged starting
one week after cranial window implantation. Imaging occurred at
2–4 day intervals.
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Figure 6. Membrane expression of EGFP-F labels dendritic
spines and axonal boutons (A–C) Detailed confocal microscopy
images show that the farnesylation site on EGFP-F targets its expression
predominantly to the membrane surface in TLG 1157+ Cre 3487+ mice.
EGFP-F labels large and small dendritic spines. (C) Terminaux (t) and en
passant (ep) axonal boutons are clearly labeled by EGFP-F. (D) Z-
projection of a stack acquired by in vivo two photon imaging of the
visual cortex of a ten week old TLG 498+ Cre 3487+ transgenic animal.
The collapsed image shows dendrites of two neighboring layer V
pyramidal neurons, 75–100 mm from the pial surface. Dendritic
protrusions (D1) and axonal boutons (D2) are clearly visible. (E–F) Z-
projections of stacks acquired by chronic in vivo two photon imaging of
the visual cortex of a 4 month old TLG 1157+ Cre 3487+ transgenic
animal. Dendrites with dendritic spines of different pyramidal neurons
imaged 7 and 9 days (E) and 12 and 15 days (F) after window
implantation, 75–100 mm from the pial surface.
doi:10.1371/journal.pone.0003059.g006
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